Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Gliosarcoma 4Glioblastoma 4Uterine Cervical Neoplasms 3Vaginal Neoplasms 2Oligodendroglioma 2Glioma, Subependymal 2Glioma 2Ependymoma 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Skin Neoplasms 1Sarcoma, Ewing 1Prostatic Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Ganglioneuroblastoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Carcinosarcoma 1Carcinoma, Endometrioid 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 50Paclitaxel 48Cisplatin 39Gemcitabine 31Erlotinib Hydrochloride 30Radiotherapy 28Docetaxel 24Taxes 21Specimen Handling 20Magnetic Resonance Spectroscopy 20Vinorelbine 16Pemetrexed 12Etoposide 12Bevacizumab 12Radiation 10Gefitinib 10aldesleukin 8Platinum 8Bortezomib 8Biopsy 8Vinblastine 7Azacitidine 71,2-diaminocyclohexaneplatinum II citrate 7pembrolizumab 6atezolizumab 6Observation 6Immunoglobulin G 6Disulfides 6Cyclophosphamide 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Carcinoma, Non-Small-Cell Lung × Congresses as Topic × Clear all
NCT04989283 2023-09-26

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00005065 2013-06-04

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡